Short sellers are busy this week. Data from August 11 shows sharp moves across biotech, consumer names, and a surprise in the private-prison sector.
CoreCivic saw the sharpest week-on-week jump among mid-caps. SI % of FF leapt from 2.4% to 10.2% — a near-fourfold rise in seven days. The move follows renewed debate around federal detention policy.
Replimune is another standout. SI climbed to 43.8% of free float, up from 35.7% last week — an 8-point spike. The cancer-therapy biotech carries a cost to borrow of just 0.8%, suggesting bears still have easy access.
Chewy remains the most striking large-cap on the screen. SI sits at 95.6% of free float — deep short territory. Availability is ample at 477%, so pressure has not yet triggered a squeeze.
Hertz continues to attract attention on social platforms. SI holds at 68.9% of float. Availability is zero. Cost to borrow is 27.9%. Those are squeeze conditions worth watching.
EverCommerce carries the highest ORTEX short score among mid-caps at 94.9. Cost to borrow jumped to 60%. Shares available to borrow equal just 2% of short interest — the tightest squeeze setup in the screen.
On the other side, ORTEX data shows UDR shorts retreating fast. SI fell 21% in a single day to 2.4% of float, down 44.9% over the past month.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
